Zydus Lifesciences Ltd gets 10 observations from USFDA for Jarod injectable facility

USFDA conducted an inspection at the Injectable Manufacturing site situated at Jarod, near Vadodara. The inspection was conducted from April 15 to April 23, 2024.

The inspection closed with 10 observations. The Company will closely work with the USFDA to address and respond to the observations in an expeditious manner.

Shares of Cadila Healthcare Limited was last trading in BSE at Rs. 959.55 as compared to the previous close of Rs. 959.45. The total number of shares traded during the day was 28112 in over 2407 trades.

The stock hit an intraday high of Rs. 965.00 and intraday low of 945.05. The net turnover during the day was Rs. 26876246.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 USFDA Form483 10Observations Jarod InjectableManufacturingFacility